Announcements Trials
Browse Landscape

Phase

Phase 2 7Phase NA 1Phase 1/2 1Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Leukemia, Myeloid, Acute 14Precursor Cell Lymphoblastic Leukemia-Lymphoma 11Lymphoma 10Leukemia 10Myelodysplastic Syndromes 9Multiple Myeloma 9Leukemia, Lymphocytic, Chronic, B-Cell 9Congenital Abnormalities 9Lymphoma, Follicular 8Hodgkin Disease 8Recurrence 7Lymphoma, Non-Hodgkin 7Lymphoma, Mantle-Cell 7Lymphoma, Large-Cell, Immunoblastic 7Lymphoma, Large B-Cell, Diffuse 7Primary Myelofibrosis 6Neoplasms, Plasma Cell 6Lymphoma, B-Cell, Marginal Zone 6Leukemia, Myelomonocytic, Chronic 6Leukemia, Myeloid, Chronic-Phase 6Burkitt Lymphoma 6Blast Crisis 6Myeloproliferative Disorders 5Lymphoma, T-Cell, Cutaneous 5Leukemia, Myeloid, Accelerated Phase 5Dendritic Cell Sarcoma, Interdigitating 5Polycythemia Vera 4Anemia, Refractory, with Excess of Blasts 4Waldenstrom Macroglobulinemia 3Thrombocythemia, Essential 3

Interventions

fludarabine 1Voriconazole 1Thalidomide 1Semen Analysis 1Remote Patient Monitoring 1Physical Examination 1Interviews as Topic 1Health Information Exchange 1Granulocyte Colony-Stimulating Factor 1Genetic Testing 1Fluconazole 1Exercise 1Dexamethasone 1Cyclophosphamide 1Complementary Therapies 1Cell- and Tissue-Based Therapy 1Busulfan 1Bone Marrow Transplantation 1Blood Specimen Collection 1Bismuth 1Alemtuzumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Hematologic Diseases × Busulfan × Clear all
NCT00582894 2011-04-22

Reduced-Intensity Allogeneic Hematopoietic Stem Cell Transplantation for Malignant Hematological Diseases

University of Oklahoma

Phase NA Completed
17 enrolled 9 charts
Other hematologic neoplasm

Hematologic Diseases, Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡